Dahlman Rose Starts Rosetta Resources (ROSE) at Buy; Eagle Ford Shale Production Expected to More Than Double in 2011
Tweet
Share
E-mailGet Alerts ROSE Hot Sheet
Price: $11.66 --0%
Rating Summary:
11 Buy, 12 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
11 Buy, 12 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Dahlman Rose initiates coverage on Rosetta Resources (NASDAQ: ROSE) with a Buy. PT $65.
Dahlman analyst says, "We view Rosetta Resources as an interesting opportunity, given the company’s leverage to the Eagle Ford Shale in southeast Texas and potential catalysts from an emerging oily play in Montana, known as the Alberta Basin Bakken. The company continues to increase its liquids exposure; we forecast liquids will account for 55% of production by 4Q12, up from 33% in 1Q11. In addition, if the Alberta Bakken play works, we expect significant upside in valuation, given the company's 300K net acreage position."
For more ratings news on Rosetta Resources click here and for the rating history of Rosetta Resources click here.
Shares of Rosetta Resources closed at $55.93 yesterday.
Dahlman analyst says, "We view Rosetta Resources as an interesting opportunity, given the company’s leverage to the Eagle Ford Shale in southeast Texas and potential catalysts from an emerging oily play in Montana, known as the Alberta Basin Bakken. The company continues to increase its liquids exposure; we forecast liquids will account for 55% of production by 4Q12, up from 33% in 1Q11. In addition, if the Alberta Bakken play works, we expect significant upside in valuation, given the company's 300K net acreage position."
For more ratings news on Rosetta Resources click here and for the rating history of Rosetta Resources click here.
Shares of Rosetta Resources closed at $55.93 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ICICI Securities Resumes Oberoi Realty Ltd (OBER:IN) at Buy (1)
- Raymond James Starts SpyGlass Pharma (SGP) at Outperform
- RBC Capital Starts Krystal Biotech (KRYS) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Bakken FormationSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
